COLOSSUS PI Dr Sadanandam, of The Institute of Cancer Research, London is the co-senior author of a breakthrough pancreatic cancer study. The co-senior author is Costas Lyssiotis at the University of Michigan. The open-access paper, titled: Uridine-derived ribose fuels glucose-restricted pancreatic cancer was published in Nature on May 17th, 2023. The article has shown some implications for colorectal cancer.
Citation: Nwosu, Z. C., Ward, M. H., Sajjakulnukit, P., Poudel, P., Ragulan, C., Kasperek, S., Radyk, M., Sutton, D., Menjivar, R. E., Andren, A., J., J., Tolstyka, Z., Brown, K., Lee, H., Dzierozynski, L. N., He, X., PS, H., Ugras, J., Nyamundanda, G., . . . Lyssiotis, C. A. (2023). Uridine-derived ribose fuels glucose-restricted pancreatic cancer. Nature, 1-8. https://doi.org/10.1038/s41586-023-06073-w